iDEL Therapeutics GmbH | $10,381,635 | (Mar 18, 2026)
Surf AI(1) | $57,000,000 | (Mar 18, 2026)
R1 Therapeutics | $77,500,000 | (Mar 18, 2026)
Growfin.ai
United States
- Wilmington, Delaware
- 07/03/2023
- Series A
- $7,500,000
Growfin is the modern accounts receivable automation software that helps enterprises accelerate cash collections and makes cash flows more predictable by giving real-time visibility into receivables, making collections smarter and more collaborative, and automating manual processes.
- Industry Software Development
- Website https://www.growfin.ai/
- LinkedIn https://www.linkedin.com/company/growfinapp/
Related People
Aravind GopalaCo Founder
United States -
ND
Building Growfin.ai
Growfin.ai is an end-to-end AR automation software that helps enterprises accelerate cash collections from customers and provide CFOs visibility & predictability into cash inflow by streamlining & automating the invoice to cash process & make collections smarter.
Reach out to me(DM) if you are interested to know more about,
how we help cash inflow more predictable, get paid faster while providing a great customer experience for enterprises.
Previously Co-founded Frilp.com, an IIM Ahmedabad incubated startup acquired by Freshworks in 2015
Product @ Freshworks, Managed Freshteam(HRMS software) & FreshId (Identity Mgmt service/ SSO service)
Quorus | $5,000,000 | (Mar 18, 2026)
BambooBox | $6,600,000 | (Mar 18, 2026)
Conduit Health | $17,000,000 | (Mar 18, 2026)
SEQUENTIAL | $3,500,000 | (Mar 18, 2026)
Standard Template Labs | $49,000,000 | (Mar 18, 2026)
Tenkara | $7,000,000 | (Mar 18, 2026)
Turquoise(US) | $40,000,000 | (Mar 18, 2026)
Malama Health | $9,200,000 | (Mar 17, 2026)
AgZen | $10,000,000 | (Mar 17, 2026)